domingo, 7 de noviembre de 2021

The Association of ERBB2-Low Expression With the Efficacy of Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer KKH Bao et al, JAMA Network Open, November 5, 2021

Main|Search|PHGKB

No hay comentarios:

Publicar un comentario